Last reviewed · How we verify

Hypotonic fluid — Competitive Intelligence Brief

Hypotonic fluid (Hypotonic fluid) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Intravenous fluid therapy / Electrolyte solution. Area: Critical Care / Fluid and Electrolyte Management.

phase 3 Intravenous fluid therapy / Electrolyte solution Critical Care / Fluid and Electrolyte Management Small molecule Live · refreshed every 30 min

Target snapshot

Hypotonic fluid (Hypotonic fluid) — All India Institute of Medical Sciences. Hypotonic fluid reduces serum osmolality by providing free water, promoting water movement into cells and reducing extracellular fluid volume.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Hypotonic fluid TARGET Hypotonic fluid All India Institute of Medical Sciences phase 3 Intravenous fluid therapy / Electrolyte solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Intravenous fluid therapy / Electrolyte solution class)

  1. All India Institute of Medical Sciences · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Hypotonic fluid — Competitive Intelligence Brief. https://druglandscape.com/ci/hypotonic-fluid. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: